Short Interest Update USMIRA

MIRA Pharmaceuticals: Extreme Short Squeeze Potential

MIRA Pharmaceuticals (MIRA) is showing extreme short-selling activity with 56.6% of float shorted, signaling high squeeze risk.

By The Forensic Ledger Desk October 1, 20261 min read

Company

Mira Pharmaceuticals

Short % Float

56.6%

Days to Cover

MIRA Short Interest Update

MIRA Pharmaceuticals (MIRA) has been identified as an extreme short squeeze candidate. With a staggering 56.6% of its float currently sold short, the stock is experiencing intense bearish pressure. This level of short interest, combined with recent price volatility, suggests that any upward movement could trigger a massive short covering event. Investors should treat this as a high-risk, high-volatility situation as short sellers and buyers collide.

Source

Signal data sourced from AltIndex. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.

#Short Interest#Squeeze#Pharma

Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.

Commission a Report · The Forensic Ledger Desk

Forensic Research & Investigations

We conduct deep investigative research into publicly traded companies — deploying forensic accountants, field investigators, and industry experts to uncover business fraud (overstated revenues), accounting fraud (inflated profits), or severe fundamental business flaws.

Commission us to compose a short-seller research report on a company you target. Every dossier is built to evidentiary standards — sourced, falsifiable, and ready to move markets.

Commission a Report

Business Fraud

Overstated revenues, fake channels, pulled-forward demand.

Accounting Fraud

Inflated profits, aggressive recognition, hidden liabilities.

Fundamental Flaws

Structural business defects the market has mispriced.

The Negative PR Blog

The internet's leading source on negative PR campaigns, smear campaigns, bad press, and reputation warfare — real, recent events documented and dissected by our reporters, with expert analysis of how we'd respond.

Read the Blog